These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3497490)

  • 1. [General practice-relevant diagnostic and differential diagnostic aspects of collagen diseases. 1: Systemic lupus erythematosus].
    Apostoloff E; Sönnichsen N
    Z Arztl Fortbild (Jena); 1987; 81(8):385-7. PubMed ID: 3497490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological aspects of antinuclear antibodies in systemic lupus erythematosus].
    Speranskiĭ AI; Aroian AA; Ivanova SM; Panasiuk AF; Riazantseva TA
    Revmatologiia (Mosk); 1987; (3):28-34. PubMed ID: 2446367
    [No Abstract]   [Full Text] [Related]  

  • 3. [The diagnostic and differential diagnostic value of anti-DNA antibodies in collagen diseases, especially in disseminated lupus erythematosus].
    Małdyk H; Chwalińska-Sodowska H; Grabowska A; Swierczynska Z; Rdułtowska B
    Verh Dtsch Ges Rheumatol; 1978; 5():107-9. PubMed ID: 309225
    [No Abstract]   [Full Text] [Related]  

  • 4. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic lupus erythematosus and antinuclear factors, with special reference to its diagnostic significance and relationship to the etiology of lupus nephritis].
    Nagasawa T
    Saishin Igaku; 1969 Oct; 24(10):2082-96. PubMed ID: 5307586
    [No Abstract]   [Full Text] [Related]  

  • 6. Appropriate laboratory testing in rheumatic diseases.
    Metzger AL; Morris RI
    Lippincotts Prim Care Pract; 1998; 2(1):52-65. PubMed ID: 9451199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication.
    Bitter T
    Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrications of connective tissue diseases.
    Mielants H; Veys EM; Verbruggen G; Coigne E; de Bussere A; Decrans L; Gabriel P; Poriau S; Raeman F; van der Jeught J
    Acta Rhumatol Belg; 1978; 2(3-4):141-62. PubMed ID: 316263
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic lupus erythematosus].
    Dobrokhodova TM
    Feldsher Akush; 1991 May; 56(5):37-40. PubMed ID: 1874320
    [No Abstract]   [Full Text] [Related]  

  • 12. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic and therapeutic possibilities in the early stage of systemic lupus erythematosus].
    Goebel KM; Krause A; Leyhe A; Klepzig M; Kolb G; Kohl FV
    Internist (Berl); 1986 Mar; 27(3):175-84. PubMed ID: 3519504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic lupus erythematosus and tuberculosis].
    Dettlaff Z
    Wiad Lek; 1972 Sep; 25(18):1667-74. PubMed ID: 4117569
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differential diagnosis of initial manifestations of systemic lupus erythematosus].
    Schwick N; Schmitz S; Dellanna F; Neveling M; Gheorghiu T
    Med Klin (Munich); 1993 Feb; 88(2):85-7. PubMed ID: 8450814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the onset of systemic lupus erythematosus in an adolescent with the symptoms of acute diffuse peritonitis].
    Kirsanov AI; Egorova LP; Nikolaeva LA
    Revmatologiia (Mosk); 1991; (2):37-8. PubMed ID: 1925264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic tests and monitoring of systemic lupus erythematosus].
    Yoshinoya S
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1355-9. PubMed ID: 2269808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.